Fortress Biotech, Inc.FBIONASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+40.2%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+40.2%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
2.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 77.83% |
| Q2 2025 | -40.88% |
| Q1 2025 | -51.57% |
| Q4 2024 | 35.65% |
| Q3 2024 | 8.15% |
| Q2 2024 | 13.98% |
| Q1 2024 | 27.46% |
| Q4 2023 | -96.84% |
| Q3 2023 | 46.65% |
| Q2 2023 | 22.89% |
| Q1 2023 | 36.70% |
| Q4 2022 | -54.14% |
| Q3 2022 | 28.25% |
| Q2 2022 | -28.08% |
| Q1 2022 | -14.20% |
| Q4 2021 | -44.35% |
| Q3 2021 | 25.61% |
| Q2 2021 | -77.46% |
| Q1 2021 | -0.42% |
| Q4 2020 | 17.25% |
| Q3 2020 | -44.25% |
| Q2 2020 | 21.94% |
| Q1 2020 | 20.42% |
| Q4 2019 | -48.61% |
| Q3 2019 | 30.93% |
| Q2 2019 | -13.07% |
| Q1 2019 | -14.29% |
| Q4 2018 | 12.76% |
| Q3 2018 | 18.76% |
| Q2 2018 | -11.18% |
| Q1 2018 | -3.72% |
| Q4 2017 | -1.76% |
| Q3 2017 | -11.91% |
| Q2 2017 | -94.23% |
| Q1 2017 | 35.66% |
| Q4 2016 | -70.89% |
| Q3 2016 | 2.76% |
| Q2 2016 | 18.12% |
| Q1 2016 | -82.16% |
| Q4 2015 | -18.14% |